explore -WSS

explore

author：knowledge 2025-09-29 19:06:22 - browse：417

Diversity in clinical trials concept — Adobe

The persistent lack of diversity among participants in clinical trials is a critical issue that is harming both populations that have long been left out of pivotal medical studies and the entire biomedical research enterprise, according to the authors of a report released Tuesday by the National Academies of Sciences, Engineering and Medicine.

Describing the need to move away from trials that focus largely on white men as “urgent,” the report’s authors called for a paradigm shift that gives less power to institutions that fund and conduct clinical research and more to communities under study. The sternly worded report said funding to include and recruit more diverse participants should be a priority that is enforced and said such investments could eventually lead to massive cost savings as the nation’s health disparities are reduced.

“An equitable clinical research enterprise would include trials and studies that match the demographics of the disease burden under study,” the report said. “However, we remain far from achieving this goal.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Gain of function research would be limited under House proposal

WSS

U.K. sequencing study surfaces new findings about tumor DNA

Readout LOUD podcast: A CRISPR milestone, biotech mixology

Poor hospice wound care hurts patients and families

David Sabatini, ex

Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

Goldman Sachs launches $650M fund for life science investments

explore

explore

focus

Virginia high school admissions case could be legal follow

Anthos stroke drug appears safer than common blood thinner

Medical records are filled with copy

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Peter Hotez and the public health issue of online harassment

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Childhood cancer progress stalls for Black, Hispanic kids: Report

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Hospitals look to new technology to keep health care workers safe

Wikipedia

UCB departs biotech trade group BIO

A daunting task: navigating dual Medicare, Medicaid eligibility

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

Federal weight loss drug coverage is 30 years out of date

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

FDA's Woodcock to retire early next year

leisure time

leisure time

Wikipedia

explore